FBXL4
Basic information
Region (hg38): 6:98868535-98948006
Links
Phenotypes
GenCC
Source:
- mitochondrial DNA depletion syndrome 13 (Supportive), mode of inheritance: AR
- Leigh syndrome (Definitive), mode of inheritance: AR
- mitochondrial DNA depletion syndrome 13 (Strong), mode of inheritance: AR
- mitochondrial DNA depletion syndrome 13 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Mitochondrial DNA depletion syndrome 13 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Craniofacial; Neurologic; Ophthalmologic | 23993193; 23993194 |
ClinVar
This is a list of variants' phenotypes submitted to
- Mitochondrial DNA depletion syndrome 13 (19 variants)
- not provided (11 variants)
- Inborn genetic diseases (4 variants)
- Mitochondrial DNA depletion syndrome (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FBXL4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 45 | 36 | 85 | |||
missense | 23 | 253 | 277 | |||
nonsense | 11 | 20 | ||||
start loss | 1 | |||||
frameshift | 20 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 2 | 1 | 10 | 5 | 18 | |
non coding | 21 | 27 | 13 | 61 | ||
Total | 22 | 45 | 323 | 63 | 18 |
Highest pathogenic variant AF is 0.000144
Variants in FBXL4
This is a list of pathogenic ClinVar variants found in the FBXL4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-98874188-C-G | Likely benign (Nov 09, 2018) | |||
6-98874260-T-C | Mitochondrial DNA depletion syndrome 13 | Uncertain significance (Aug 10, 2017) | ||
6-98874267-C-T | Mitochondrial DNA depletion syndrome 13 | Uncertain significance (Aug 10, 2017) | ||
6-98874269-T-C | Mitochondrial DNA depletion syndrome 13 | Conflicting classifications of pathogenicity (May 23, 2023) | ||
6-98874273-T-C | Mitochondrial DNA depletion syndrome 13 • FBXL4-related disorder | Benign (Feb 04, 2020) | ||
6-98874273-TTA-CTG | Mitochondrial DNA depletion syndrome 13 | Uncertain significance (Aug 10, 2017) | ||
6-98874274-T-C | Mitochondrial DNA depletion syndrome 13 | Uncertain significance (Aug 10, 2017) | ||
6-98874275-A-G | not specified • Mitochondrial DNA depletion syndrome 13 | Benign (Nov 22, 2023) | ||
6-98874285-G-C | Mitochondrial DNA depletion syndrome 13 | Uncertain significance (Aug 10, 2017) | ||
6-98874290-GCT-G | Uncertain significance (Jun 13, 2022) | |||
6-98874298-T-C | Uncertain significance (Mar 29, 2022) | |||
6-98874306-A-T | Mitochondrial DNA depletion syndrome 13 | Likely pathogenic (Aug 10, 2017) | ||
6-98874307-C-G | Inborn genetic diseases | Uncertain significance (Feb 17, 2023) | ||
6-98874307-CT-C | Mitochondrial DNA depletion syndrome 13 | Likely pathogenic (Aug 10, 2017) | ||
6-98874313-G-C | Uncertain significance (Aug 27, 2021) | |||
6-98874318-C-T | Mitochondrial DNA depletion syndrome 13 | Uncertain significance (Aug 01, 2022) | ||
6-98874348-T-C | Mitochondrial DNA depletion syndrome 13 | Uncertain significance (Aug 10, 2017) | ||
6-98874354-T-G | Mitochondrial DNA depletion syndrome 13 • not specified | Conflicting classifications of pathogenicity (Mar 08, 2024) | ||
6-98874356-C-A | Mitochondrial DNA depletion syndrome 13 | Uncertain significance (Aug 10, 2017) | ||
6-98874356-C-T | Mitochondrial DNA depletion syndrome 13 | Conflicting classifications of pathogenicity (May 28, 2022) | ||
6-98874356-CG-C | Mitochondrial DNA depletion syndrome 13 | Likely pathogenic (Feb 15, 2022) | ||
6-98874357-G-A | Mitochondrial DNA depletion syndrome 13 | Uncertain significance (Aug 20, 2022) | ||
6-98874360-C-G | Mitochondrial DNA depletion syndrome 13 | Uncertain significance (Aug 31, 2022) | ||
6-98874365-G-A | Mitochondrial DNA depletion syndrome 13 | Uncertain significance (Aug 10, 2017) | ||
6-98874366-G-C | Mitochondrial DNA depletion syndrome 13 | Uncertain significance (Aug 10, 2017) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FBXL4 | protein_coding | protein_coding | ENST00000369244 | 7 | 79430 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.14e-8 | 0.934 | 125660 | 0 | 86 | 125746 | 0.000342 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.555 | 299 | 327 | 0.914 | 0.0000161 | 4073 |
Missense in Polyphen | 82 | 105.55 | 0.77691 | 1258 | ||
Synonymous | -0.101 | 123 | 122 | 1.01 | 0.00000601 | 1218 |
Loss of Function | 1.90 | 17 | 27.8 | 0.612 | 0.00000159 | 315 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00103 | 0.00102 |
Ashkenazi Jewish | 0.000298 | 0.000298 |
East Asian | 0.000381 | 0.000381 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000407 | 0.000404 |
Middle Eastern | 0.000381 | 0.000381 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Pathway
- Post-translational protein modification;Metabolism of proteins;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Neddylation
(Consensus)
Recessive Scores
- pRec
- 0.0992
Intolerance Scores
- loftool
- 0.662
- rvis_EVS
- -0.93
- rvis_percentile_EVS
- 9.55
Haploinsufficiency Scores
- pHI
- 0.429
- hipred
- N
- hipred_score
- 0.414
- ghis
- 0.606
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.647
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fbxl4
- Phenotype
Gene ontology
- Biological process
- protein polyubiquitination;ubiquitin-dependent protein catabolic process;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;post-translational protein modification
- Cellular component
- ubiquitin ligase complex;mitochondrial intermembrane space;cytosol;nuclear speck;SCF ubiquitin ligase complex
- Molecular function
- ubiquitin-protein transferase activity